| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $14.73B | $13.69B | $12.84B |
| YoY Revenue Growth % | +7.6% | +6.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.87B | $1.32B | $1.03B |
| Operating Margin % | 12.7% | 9.6% | 8.0% |
| Net Income (GAAP) | $1.30B | $1.22B | $688.0M |
| EBITDA (Normalized) | $2.49B | $1.92B | $1.50B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.88B | $3.08B | $2.69B |
| Capital Expenditures (CapEx) | $770.0M | $756.0M | $577.8M |
| Free Cash Flow (FCF) | $3.11B | $2.33B | $2.11B |
| FCF Margin % | 21.1% | 17.0% | 16.5% |
| Return on Invested Capital (ROIC %) | 95.0% | 40.1% | 7.6% |
| Cash & Short-Term Equivalents | $5.41B | $4.18B | — |
| Total Debt (Short + Long Term) | $4.47B | $5.22B | $4.17B |
| Total Stockholders' Equity | $1.28B | $1.56B | $8.55B |